BACHEM HOLDING AG (BANB.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH1176493729
BACHEM HOLDING AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 605.26 m CHF | 695.07 m CHF |
| Gross profit | 182.56 m CHF | 199.73 m CHF |
| Operating income | 133.05 m CHF | 167.30 m CHF |
| Net income | 120.25 m CHF | 148.79 m CHF |
| Diluted EPS – continuing operations | 1.60 CHF | 1.98 CHF |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BACHEM HOLDING AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
More stocks
- Shimadzu Corp (SHMXY)
- Jiangxi Redboard Tech Co Ltd (603459.SS)
- ISS A/S (ISS.CO)
- Wharf Holdings Ltd (4.HK)
- Shenzhen Megmeet Electrical Co Ltd (002851.SZ)
- Beijer Ref AB (publ) (BEIJ B.ST)
- BKW AG (BKW.SW)
- Motiva Infraestrutura de Mobilidade S.A. (MOTV3.SA)
- LINCOLN NATIONAL CORP (LNC)
- HEALTHEQUITY, INC. (HQY)
- SalMar ASA (SALM.OL)
- Vista Oil & Gas S.A.B. de C.V (VISTAA.MX)
Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.